应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02171 科济药业-B
未开盘 12-23 16:08:09
15.230
+0.080
+0.53%
最高
15.770
最低
14.950
成交量
136.25万
今开
15.000
昨收
15.150
日振幅
5.41%
总市值
86.96亿
流通市值
86.96亿
总股本
5.71亿
成交额
2,082万
换手率
0.24%
流通股本
5.71亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
科济药业-B(02171)12月23日斥资486.09万港元回购32万股
智通财经 · 12-23 21:16
科济药业-B(02171)12月23日斥资486.09万港元回购32万股
天价“抗癌针”成本有望降至万元以内——专访科济药业董事会主席李宗海
中国基金报 · 12-23 20:23
天价“抗癌针”成本有望降至万元以内——专访科济药业董事会主席李宗海
非执行董事郭华清增持科济药业(02171)1.8万股 每股作价14.52港元
智通财经网 · 12-22 19:06
非执行董事郭华清增持科济药业(02171)1.8万股 每股作价14.52港元
每日卖空追踪 | 科济药业-B 12月22日卖空量成交4.85万股,卖空比例为3.59%
市场透视 · 12-22 16:30
每日卖空追踪 | 科济药业-B 12月22日卖空量成交4.85万股,卖空比例为3.59%
科济药业-B12月22日主力净流入325.2万元 散户资金抛售
市场透视 · 12-22 16:16
科济药业-B12月22日主力净流入325.2万元 散户资金抛售
科济药业:回购计划延期 主要股东同步增持 认为当前股价低估
财中社 · 12-19
科济药业:回购计划延期 主要股东同步增持 认为当前股价低估
非执行董事郭华清增持科济药业(02171)3万股 每股作价14.98港元
智通财经 · 12-18
非执行董事郭华清增持科济药业(02171)3万股 每股作价14.98港元
智通港股回购统计|12月18日
智通财经 · 12-18
智通港股回购统计|12月18日
科济药业-B于12月17日斥资673.7万港元回购46.6万股
新浪港股 · 12-18
科济药业-B于12月17日斥资673.7万港元回购46.6万股
科濟藥業控股(02171)回购46.6万股股份,总额约673.7万港元
公告速递 · 12-17
科濟藥業控股(02171)回购46.6万股股份,总额约673.7万港元
每日卖空追踪 | 科济药业-B 12月17日卖空量成交6.35万股,卖空比例为2.94%
市场透视 · 12-17
每日卖空追踪 | 科济药业-B 12月17日卖空量成交6.35万股,卖空比例为2.94%
智通港股回购统计|12月17日
智通财经 · 12-17
智通港股回购统计|12月17日
科济药业-B(02171)12月16日斥资1476.2万港元回购101万股
智通财经 · 12-16
科济药业-B(02171)12月16日斥资1476.2万港元回购101万股
每日卖空追踪 | 科济药业-B 12月16日卖空量成交8.7万股,卖空比例为2.54%
市场透视 · 12-16
每日卖空追踪 | 科济药业-B 12月16日卖空量成交8.7万股,卖空比例为2.54%
科济药业-B(02171)12月15日斥资790.76万港元回购52.2万股
智通财经 · 12-15
科济药业-B(02171)12月15日斥资790.76万港元回购52.2万股
科济药业-B(02171)12月12日斥资389.45万港元回购25万股
智通财经网 · 12-12
科济药业-B(02171)12月12日斥资389.45万港元回购25万股
智通港股回购统计|12月12日
智通财经 · 12-12
智通港股回购统计|12月12日
mPFS 50.4个月,ORR 100%:多发性骨髓瘤CAR-T之争
研发客 · 12-12
mPFS 50.4个月,ORR 100%:多发性骨髓瘤CAR-T之争
科济药业-B(02171)12月11日耗资约1588.62万港元回购102万股
智通财经 · 12-11
科济药业-B(02171)12月11日耗资约1588.62万港元回购102万股
非执行董事郭华清减持科济药业(02171)1万股 每股作价17.7港元
智通财经 · 12-11
非执行董事郭华清减持科济药业(02171)1万股 每股作价17.7港元
加载更多
公司概况
公司名称:
科济药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。该公司的主营业务是从事开发嵌合抗原受体T细胞(CAR-T)细胞疗法,以满足临床需求,包括但不限于血液恶性肿瘤、实体瘤及自身免疫性疾病。该公司的主要产品包括赛恺泽(泽沃基奥仑赛注射液)、舒瑞基奥仑赛注射液、通用型CAR-T细胞产品。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"科济药业-B","latestPrice":15.23,"timestamp":1766477289003,"preClose":15.15,"halted":0,"volume":1362500,"delay":0,"floatShares":571000000,"shares":571000000,"eps":-1.5997605463086833,"marketStatus":"未开盘","change":0.08,"latestTime":"12-23 16:08:09","open":15,"high":15.77,"low":14.95,"amount":20817612,"amplitude":0.054125,"askPrice":15.23,"askSize":500,"bidPrice":15.15,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.051764638023831,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":0,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":15.15,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":0.7289602282665568,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171","defaultTab":"news","newsList":[{"id":"2593418349","title":"科济药业-B(02171)12月23日斥资486.09万港元回购32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418349","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593418349?lang=zh_cn&edition=full","pubTime":"2025-12-23 21:16","pubTimestamp":1766495776,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B(02171)发布公告,于2025年12月23日该公司斥资486.09万港元回购32万股,回购价格为每股14.98-15.25港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385151.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK1587","BK1161","BK1574","02171"],"gpt_icon":0},{"id":"2593497198","title":"天价“抗癌针”成本有望降至万元以内——专访科济药业董事会主席李宗海","url":"https://stock-news.laohu8.com/highlight/detail?id=2593497198","media":"中国基金报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593497198?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:23","pubTimestamp":1766492630,"startTime":"0","endTime":"0","summary":"【导读】科济药业董事会主席李宗海:通用型CAR-T产品有望将成本降至1万元/针左右作为革命性的癌症免疫治疗方法,CAR-T细胞疗法被认为是目前最有前景的肿瘤治疗方式之一,但其高达百万元的治疗费用却让众多普通患者望而却步。不过,此种状况有望迎来积极的变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233599719764.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599719764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02171","BK1161","BK1587","BK1585","BK1574"],"gpt_icon":0},{"id":"2593481733","title":"非执行董事郭华清增持科济药业(02171)1.8万股 每股作价14.52港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593481733","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593481733?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:06","pubTimestamp":1766401576,"startTime":"0","endTime":"0","summary":"12月18日,非执行董事郭华清增持科济药业(02171)1.8万股,每股作价14.52港元,总金额约为26.14万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20251222/20251222190654_25742.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251222/20251222190654_25742.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"非执行董事郭华清增持科济药业(02171)1.8万股 每股作价14.52港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1585","BK1574","02171","BK1161","BK1587"],"gpt_icon":0},{"id":"2593408430","title":"每日卖空追踪 | 科济药业-B 12月22日卖空量成交4.85万股,卖空比例为3.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593408430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593408430?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392228,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月22日,涨1%,卖空量成交4.85万股,较上一交易日减少48.68%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163516a4699615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163516a4699615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","BK1585","02171","BK1161"],"gpt_icon":0},{"id":"2593543047","title":"科济药业-B12月22日主力净流入325.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2593543047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593543047?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:16","pubTimestamp":1766391362,"startTime":"0","endTime":"0","summary":"12月22日, 科济药业-B股价涨1.00%,报收15.15元,成交金额2017.9万元,换手率0.24%,振幅4.00%,量比0.67。科济药业-B今日主力资金净流入325.2万元,上一交易日主力净流出9.4万元。该股近5个交易日下跌0.33%,主力资金累计净流入1585.7万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2012.3万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162332a469873e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162332a469873e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1587","BK1161","BK1574","BK1585"],"gpt_icon":0},{"id":"2592136196","title":"科济药业:回购计划延期 主要股东同步增持 认为当前股价低估","url":"https://stock-news.laohu8.com/highlight/detail?id=2592136196","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592136196?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:36","pubTimestamp":1766108160,"startTime":"0","endTime":"0","summary":"科济药业-B(02171)发布公告,公司于2025年12月18日宣布其股份回购计划及主要股东增持股份的情况。根据公告,自2025年10月21日至2025年12月17日,公司已根据2025年股份回购授权共回购763万股股份。董事会认为,目前股价低于其真正价值,未能充分反映公司业务前景,因此继续推进股份回购计划,并已将该计划的期限延长至下届股东周年大会结束为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512193596439827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","02171","BK1585","BK1587"],"gpt_icon":0},{"id":"2592897845","title":"非执行董事郭华清增持科济药业(02171)3万股 每股作价14.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592897845","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592897845?lang=zh_cn&edition=full","pubTime":"2025-12-18 15:35","pubTimestamp":1766043318,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,12月15日,非执行董事郭华清增持科济药业(02171)3万股,每股作价14.98港元,总金额为44.94万港元。增持后最新持股数目约为2.24亿股,持股比例为38.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1585","02171","BK1574","BK1587"],"gpt_icon":0},{"id":"2592434947","title":"智通港股回购统计|12月18日","url":"https://stock-news.laohu8.com/highlight/detail?id=2592434947","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592434947?lang=zh_cn&edition=full","pubTime":"2025-12-18 09:10","pubTimestamp":1766020202,"startTime":"0","endTime":"0","summary":"其中,回购金额最大的为腾讯控股,回购数量105.70 万,回购金额6.36 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02038","02416","02598","00345","02419","00700","06078","09878","00434","01458","02517","02319","02018","01773","09857","09886","00383","02171","01681","01995","06608","02369","03798","00732","03888","06098","00947","02367","09959","00669","01588","02251","01066","01951","00175","02167","01672","06100","01919","06826","01024","00909","01317","06186","00386","02869","02158","02273","01651","02299"],"gpt_icon":1},{"id":"2592911942","title":"科济药业-B于12月17日斥资673.7万港元回购46.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592911942","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592911942?lang=zh_cn&edition=full","pubTime":"2025-12-18 08:36","pubTimestamp":1766018160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 科济药业-B(02171)发布公告,于2025年12月17日斥资673.7万港元回购46.6万股。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-12-18/doc-inhceprr6885420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02171","BK1574","BK1587","BK1585"],"gpt_icon":0},{"id":"1188572638","title":"科濟藥業控股(02171)回购46.6万股股份,总额约673.7万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188572638","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188572638?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:36","pubTimestamp":1765974985,"startTime":"0","endTime":"0","summary":"科濟藥業控股有限公司于2025年12月17日发布翌日披露报表,公告当日通过市场回购普通股466,000股,占当日前已发行股份约0.08%。本次回购价格区间为每股14.35港元至14.54港元,涉资总额约6,737,255港元。本次回购完成后,公司已发行股份总数调整为570,801,155股,库存股数增至7,172,000股,合计577,973,155股。科濟藥業控股有限公司的回购授权于2025年5月22日获股东通过,可购回股份总数57,543,590股。公司指出,本次操作已获得董事会正式授权,并遵守相关上市规则及适用法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"gpt_icon":0},{"id":"2592552975","title":"每日卖空追踪 | 科济药业-B 12月17日卖空量成交6.35万股,卖空比例为2.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592552975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592552975?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960227,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月17日,跌2.28%,卖空量成交6.35万股,较上一交易日减少78.87%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163410a6ad2528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163410a6ad2528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1585","BK1587","BK1161","BK1574"],"gpt_icon":0},{"id":"2592695160","title":"智通港股回购统计|12月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=2592695160","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592695160?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:10","pubTimestamp":1765933801,"startTime":"0","endTime":"0","summary":"其中,回购金额最大的为腾讯控股,回购数量106.70 万,回购金额6.36 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00947","01588","02018","02158","02299","02273","02869","02419","01919","01995","01810","02678","02866","01651","06868","02416","00345","02038","00386","01317","03888","01458","09959","01024","02369","00700","01681","00909","01066","02219","00732","01773","03899","06100","00434","02171","06098","09878","02367","02392","01907","08149","02251","02598","02319","00175","09886","01672","00669","06608"],"gpt_icon":1},{"id":"2591987462","title":"科济药业-B(02171)12月16日斥资1476.2万港元回购101万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591987462","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591987462?lang=zh_cn&edition=full","pubTime":"2025-12-16 21:49","pubTimestamp":1765892991,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B(02171)发布公告,于2025年12月16日斥资1476.2万港元回购101万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK1585","02171","BK1587"],"gpt_icon":0},{"id":"2591998813","title":"每日卖空追踪 | 科济药业-B 12月16日卖空量成交8.7万股,卖空比例为2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591998813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591998813?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873826,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间12月16日,跌2.94%,卖空量成交8.7万股,较上一交易日减少70.05%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163408a6a8b60b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163408a6a8b60b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1585","02171","BK1161"],"gpt_icon":0},{"id":"2591459856","title":"科济药业-B(02171)12月15日斥资790.76万港元回购52.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591459856","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591459856?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:00","pubTimestamp":1765800031,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B(02171)发布公告,于2025年12月15日斥资790.76万港元回购52.2万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1585","02171","BK1161","BK1587"],"gpt_icon":0},{"id":"2590703505","title":"科济药业-B(02171)12月12日斥资389.45万港元回购25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590703505","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590703505?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:15","pubTimestamp":1765541718,"startTime":"0","endTime":"0","summary":"科济药业-B(02171)发布公告,于2025年12月12日斥资389.45万港元回购25万股。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_25.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_25.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381106.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","02171","BK1587","BK1574","BK1585"],"gpt_icon":0},{"id":"2590523879","title":"智通港股回购统计|12月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2590523879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590523879?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:10","pubTimestamp":1765501802,"startTime":"0","endTime":"0","summary":"其中,回购金额最大的为腾讯控股,回购数量105.40 万,回购金额6.36 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02039","02219","00383","02517","01919","02369","06098","09896","00345","01458","01066","02419","00386","02018","01588","00434","01317","08188","00732","02347","09886","06826","01681","02319","03798","02273","01024","00799","02886","01907","02416","03888","01382","09878","06868","09959","02158","06186","02171","01951","02866","01810","00947","02392","02367","09869","00700","00175","02869","00909"],"gpt_icon":1},{"id":"2590526995","title":"mPFS 50.4个月,ORR 100%:多发性骨髓瘤CAR-T之争","url":"https://stock-news.laohu8.com/highlight/detail?id=2590526995","media":"研发客","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590526995?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:00","pubTimestamp":1765486842,"startTime":"0","endTime":"0","summary":"// 2025 ASH年会上,CAR-T治疗多发性骨髓瘤研究的摘要有140多个; 体内CAR-T疗法在复发难治性多发性骨髓瘤患者中MRD阴性率100%,三个月内均保持MRD阴性反应,5个月随访期内所有患者均保持应答状态; 科济、瓴路、驯鹿这些中国本土CAR-T公司的产品也崭露头角。此次在大会上公布的是 KLN-1010在Ⅰ期 inMMyCAR 研究中的首次人体试验结果。截至目前,所有观察三个月的患者均表现出持久记忆性 CAR-T 效应。事实上,KLN-1010并非首款在R/R MM患者中证明初步疗效的体内CAR-T。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212050219a4432679&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212050219a4432679&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1574","BK1585","BK1587","BK1161"],"gpt_icon":0},{"id":"2590552513","title":"科济药业-B(02171)12月11日耗资约1588.62万港元回购102万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590552513","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590552513?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:13","pubTimestamp":1765455213,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科济药业-B(02171)公布,2025年12月11日耗资约1588.62万港元回购102万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1585","BK1587","BK1161","02171"],"gpt_icon":0},{"id":"2590202597","title":"非执行董事郭华清减持科济药业(02171)1万股 每股作价17.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590202597","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590202597?lang=zh_cn&edition=full","pubTime":"2025-12-11 18:53","pubTimestamp":1765450414,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,12月8日,非执行董事郭华清减持科济药业(02171)1万股,每股作价17.7港元,总金额为17.7万港元。减持后最新持股数目约为2.18亿股,持股比例为37.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02171","BK1587","BK1574","BK1161","BK1585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":-0.0999},{"period":"3month","weight":-0.219},{"period":"6month","weight":-0.3478},{"period":"1year","weight":0.7876},{"period":"ytd","weight":0.6536}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。该公司的主营业务是从事开发嵌合抗原受体T细胞(CAR-T)细胞疗法,以满足临床需求,包括但不限于血液恶性肿瘤、实体瘤及自身免疫性疾病。该公司的主要产品包括赛恺泽(泽沃基奥仑赛注射液)、舒瑞基奥仑赛注射液、通用型CAR-T细胞产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.109168},{"month":2,"riseRate":0.75,"avgChangeRate":0.310052},{"month":3,"riseRate":0,"avgChangeRate":-0.128154},{"month":4,"riseRate":0.25,"avgChangeRate":-0.092431},{"month":5,"riseRate":0.75,"avgChangeRate":0.085205},{"month":6,"riseRate":0.5,"avgChangeRate":0.033426},{"month":7,"riseRate":0.4,"avgChangeRate":-0.015336},{"month":8,"riseRate":0.6,"avgChangeRate":0.066197},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.054112}],"exchange":"SEHK","name":"科济药业-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科济药业-B,02171,科济药业-B股票,科济药业-B股票老虎,科济药业-B股票老虎国际,科济药业-B行情,科济药业-B股票行情,科济药业-B股价,科济药业-B股市,科济药业-B股票价格,科济药业-B股票交易,科济药业-B股票购买,科济药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科济药业-B(02171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科济药业-B(02171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}